The azide group provides a selective reaction site for an alkyne-bearing target molecule. Copper-catalyzed azide–alkyne cycloaddition joins the two components and forms a triazole linkage, while strain-promoted click chemistry offers a related copper-free option. This reaction-based design allows the iodine-125-containing reagent to be connected to peptides, proteins, or small molecules through a defined chemical handle.
Formation of the triazole creates a stable connection between the radiolabeling reagent and the target molecule. That stability helps preserve the association of iodine-125 with the labeled product during chemical and biological studies. Because the attachment occurs through a modular click reaction, researchers can separate radioisotope preparation from synthesis of the final labeled peptide, protein, or small molecule.
Both approaches use the azide and a complementary alkyne to produce a triazole-linked product. Copper-catalyzed azide–alkyne cycloaddition uses copper as a reaction component, whereas strain-promoted chemistry relies on a suitably activated alkyne and avoids that catalyst. The availability of both strategies gives researchers flexibility when selecting conditions compatible with the biomolecule or experimental workflow.
Their preassembled design and defined azide functionality help organize the labeling workflow around a complementary alkyne on the target molecule. This modularity can improve labeling selectivity and provide greater control over when radioisotope preparation and target synthesis occur. The resulting organization is especially useful when the labeled product must support quantitative tracking or molecular interaction studies.
A typical workflow separates preparation of the iodine-125-containing reagent from preparation of the target molecule. The target is equipped with, or already contains, a complementary alkyne, and the two components are joined through copper-catalyzed or strain-promoted click chemistry. The resulting triazole-linked product can then be studied as a radiolabeled peptide, protein, or small molecule.
Products made with iodine-125 azide prosthetic groups can support receptor-binding assays, pharmacokinetic studies, autoradiography, and investigations of molecular interactions. In these settings, the iodine-125 label enables detection and quantitative tracking of the attached molecule. The strategy therefore connects synthetic chemistry with measurements of binding behavior, distribution, and molecular association in chemical or biological systems.